Expanded Access Protocol for Subjects With Relapsed or Refractory Advanced Solid Tumors Receiving TJ210001
Clinical trial NCT05511350 · NO_LONGER_AVAILABLE
Trial details
- NCT number
- NCT05511350
- Sponsor
- I-Mab Biopharma US Limited
- Status
- NO_LONGER_AVAILABLE
- Study type
- EXPANDED_ACCESS
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.